Akèy › Limfom selil mantèl › Maryland › Baltimore

Etid klinik pou Limfom selil mantèl nan Baltimore, MD

5 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3

The University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

Ap rekriteFaz 2

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07003295

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Ap rekriteFaz 1

University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Dec 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon

Massive Bio SYNERGY-AI site, Baltimore
Massive Bio SYNERGY-AI site, Towson · 8 mi lwen

Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Limfom selil mantèl nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.